Cost-effectiveness of posaconazole versus fluconazole or itraconazole in the prevention of invasive fungal infections among high-risk neutropenic patients in Spain

BACKGROUND: We evaluated the cost-effectiveness of posaconazole compared with standard azole therapy (SAT; fluconazole or itraconazole) for the prevention of invasive fungal infections (IFI) and the reduction of overall mortality in high-risk neutropenic patients with acute myelogenous leukaemia (AM...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Grau, Santiago, de la Cámara, Rafael, Sabater, Francisco J, Jarque, Isidro, Carreras, Enric, Casado, Miguel A, Sanz, Miguel A
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2012
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3355034/
https://ncbi.nlm.nih.gov/pubmed/22471553
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2334-12-83
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados